CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 94 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $14,409,000 | +59.1% | 2,150,641 | 0.0% | 0.42% | +47.2% |
Q2 2022 | $9,054,000 | +24.9% | 2,150,641 | 0.0% | 0.28% | +95.9% |
Q1 2022 | $7,247,000 | -46.5% | 2,150,641 | -50.0% | 0.14% | +39.4% |
Q4 2021 | $13,548,000 | +92.6% | 4,301,282 | +100.0% | 0.10% | +2.0% |
Q3 2021 | $7,033,000 | -61.3% | 2,150,641 | -50.0% | 0.10% | -13.6% |
Q2 2021 | $18,150,000 | +69.1% | 4,301,282 | +100.0% | 0.12% | -13.2% |
Q1 2021 | $10,731,000 | -60.5% | 2,150,641 | 0.0% | 0.14% | -53.4% |
Q4 2020 | $27,184,000 | +28.7% | 2,150,641 | 0.0% | 0.29% | -5.2% |
Q3 2020 | $21,119,000 | -1.3% | 2,150,641 | 0.0% | 0.31% | -11.2% |
Q2 2020 | $21,398,000 | +9.5% | 2,150,641 | 0.0% | 0.35% | -31.8% |
Q1 2020 | $19,549,000 | -1.5% | 2,150,641 | 0.0% | 0.51% | +29.2% |
Q4 2019 | $19,840,000 | +53.8% | 2,150,641 | -2.0% | 0.39% | +13.2% |
Q3 2019 | $12,904,000 | -51.2% | 2,194,641 | -0.5% | 0.35% | -42.7% |
Q2 2019 | $26,456,000 | -0.6% | 2,204,641 | 0.0% | 0.61% | -19.2% |
Q1 2019 | $26,610,000 | +16.6% | 2,204,641 | +17.7% | 0.75% | -13.6% |
Q4 2018 | $22,823,000 | +5752.1% | 1,873,779 | +8926.8% | 0.87% | +5331.2% |
Q3 2015 | $390,000 | – | 20,758 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 2,610 | $620,000,000 | 6.47% |
Parkman Healthcare Partners LLC | 1,124,072 | $4,732,000 | 1.74% |
Kynam Capital Management, LP | 1,000,000 | $4,210,000 | 1.08% |
EAM Investors, LLC | 850,647 | $3,581,000 | 0.87% |
BVF INC/IL | 3,629,000 | $15,278,000 | 0.74% |
EAM Global Investors LLC | 388,730 | $1,637,000 | 0.40% |
RA Capital Management | 3,307,203 | $13,923,000 | 0.37% |
Nantahala Capital Management | 1,659,840 | $6,988,000 | 0.35% |
AWM Investment Company, Inc. | 504,661 | $2,125,000 | 0.34% |
INGALLS & SNYDER LLC | 1,411,153 | $5,941,000 | 0.31% |